Barely Significant
← all excerpts

Personalized Drug Repurposing Screen Identifies Patient-Specific Therapeutic Candidates for Mucopolysaccharidosis Type IIIB.

J Pers Med · 2026 · PMC13412476 · PMID 42506095

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
Consequently, this platform identified highly significant differences between MPSIIIB and NHDF cells across all cell densities tested ( p < 0.0001; Figure 1 C,D).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.